Chronic kidney disease
Chronic kidney disease is a progressive disease with no cure and high morbidity and
mortality that occurs commonly in the general adult population, especially in people with …
mortality that occurs commonly in the general adult population, especially in people with …
The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019)
S Umemura, H Arima, S Arima, K Asayama… - Hypertension …, 2019 - nature.com
The Japanese Society of Hypertension (JSH) revised the Guidelines for the Management of
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …
Polycystic kidney disease
C Bergmann, LM Guay-Woodford, PC Harris… - Nature reviews Disease …, 2018 - nature.com
Cystic kidneys are common causes of end-stage renal disease, both in children and in
adults. Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive …
adults. Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive …
Autosomal dominant polycystic kidney disease
E Cornec-Le Gall, A Alam, RD Perrone - The Lancet, 2019 - thelancet.com
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary
kidney disease and one of the most common causes of end-stage kidney disease. Multiple …
kidney disease and one of the most common causes of end-stage kidney disease. Multiple …
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
P Angeli, M Bernardi, C Villanueva, C Francoz… - Journal of …, 2018 - Elsevier
The natural history of cirrhosis is characterised by an asymptomatic compensated phase
followed by a decompensated phase, marked by the development of overt clinical signs, the …
followed by a decompensated phase, marked by the development of overt clinical signs, the …
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
The global nephrology community recognises the need for a cohesive plan to address the
problem of chronic kidney disease (CKD). In July, 2016, the International Society of …
problem of chronic kidney disease (CKD). In July, 2016, the International Society of …
[HTML][HTML] Tolvaptan in later-stage autosomal dominant polycystic kidney disease
VE Torres, AB Chapman, O Devuyst… - … England Journal of …, 2017 - Mass Medical Soc
Background In a previous trial involving patients with early autosomal dominant polycystic
kidney disease (ADPKD; estimated creatinine clearance,≥ 60 ml per minute), the …
kidney disease (ADPKD; estimated creatinine clearance,≥ 60 ml per minute), the …
Renal plasticity revealed through reversal of polycystic kidney disease in mice
Initiation of cyst formation in autosomal dominant polycystic kidney disease (ADPKD) occurs
when kidney tubule cells are rendered null for either PKD1 or PKD2 by somatic 'second …
when kidney tubule cells are rendered null for either PKD1 or PKD2 by somatic 'second …
Treatment of patients with cirrhosis
PS Ge, BA Runyon - New England Journal of Medicine, 2016 - Mass Medical Soc
Treatment of Patients with Cirrhosis | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
[HTML][HTML] Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies …
AB Chapman, O Devuyst, KU Eckardt, RT Gansevoort… - Kidney international, 2015 - Elsevier
Autosomal-dominant polycystic kidney disease (ADPKD) affects up to 12 million individuals
and is the fourth most common cause for renal replacement therapy worldwide. There have …
and is the fourth most common cause for renal replacement therapy worldwide. There have …